178 related articles for article (PubMed ID: 11508855)
41. Epigenetic inactivation of BRCA1 is associated with aberrant expression of CTCF and DNA methyltransferase (DNMT3B) in some sporadic breast tumours.
Butcher DT; Rodenhiser DI
Eur J Cancer; 2007 Jan; 43(1):210-9. PubMed ID: 17071074
[TBL] [Abstract][Full Text] [Related]
42. Suppression of ING1 expression in sporadic breast cancer.
Toyama T; Iwase H; Watson P; Muzik H; Saettler E; Magliocco A; DiFrancesco L; Forsyth P; Garkavtsev I; Kobayashi S; Riabowol K
Oncogene; 1999 Sep; 18(37):5187-93. PubMed ID: 10498868
[TBL] [Abstract][Full Text] [Related]
43. Expression of Brca1 is associated with terminal differentiation of ectodermally and mesodermally derived tissues in mice.
Lane TF; Deng C; Elson A; Lyu MS; Kozak CA; Leder P
Genes Dev; 1995 Nov; 9(21):2712-22. PubMed ID: 7590247
[TBL] [Abstract][Full Text] [Related]
44. miRNA expression patterns in normal breast tissue and invasive breast cancers of BRCA1 and BRCA2 germ-line mutation carriers.
Vos S; Vesuna F; Raman V; van Diest PJ; van der Groep P
Oncotarget; 2015 Oct; 6(31):32115-37. PubMed ID: 26378051
[TBL] [Abstract][Full Text] [Related]
45. Overexpression of a protein fragment of RNA helicase A causes inhibition of endogenous BRCA1 function and defects in ploidy and cytokinesis in mammary epithelial cells.
Schlegel BP; Starita LM; Parvin JD
Oncogene; 2003 Feb; 22(7):983-91. PubMed ID: 12592385
[TBL] [Abstract][Full Text] [Related]
46. Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours.
Veeck J; Bektas N; Hartmann A; Kristiansen G; Heindrichs U; Knüchel R; Dahl E
Breast Cancer Res; 2008; 10(5):R82. PubMed ID: 18826564
[TBL] [Abstract][Full Text] [Related]
47. Correlation between BRCA1 expression and apoptosis-related biological parameters in sporadic breast carcinomas.
Yang Q; Yoshimura G; Nakamura M; Nakamura Y; Suzuma T; Umemura T; Mori I; Sakurai T; Kakudo K
Anticancer Res; 2002; 22(6B):3615-9. PubMed ID: 12552965
[TBL] [Abstract][Full Text] [Related]
48. Down-regulation of the zinc-finger homeobox protein TSHZ2 releases GLI1 from the nuclear repressor complex to restore its transcriptional activity during mammary tumorigenesis.
Riku M; Inaguma S; Ito H; Tsunoda T; Ikeda H; Kasai K
Oncotarget; 2016 Feb; 7(5):5690-701. PubMed ID: 26744317
[TBL] [Abstract][Full Text] [Related]
49. Influence of genistein and daidzein on Brca1 protein levels in human breast cell lines.
Bernard-Gallon DJ; Maurizis JC; Rio PG; Bignon YJ
J Natl Cancer Inst; 1998 Jun; 90(11):862-3. PubMed ID: 9625177
[No Abstract] [Full Text] [Related]
50. Functional domains of the BRCA1 and BRCA2 proteins.
Baer R; Lee WH
J Mammary Gland Biol Neoplasia; 1998 Oct; 3(4):403-12. PubMed ID: 10819534
[TBL] [Abstract][Full Text] [Related]
51. Alternative and aberrant messenger RNA splicing of the mdm2 oncogene in invasive breast cancer.
Lukas J; Gao DQ; Keshmeshian M; Wen WH; Tsao-Wei D; Rosenberg S; Press MF
Cancer Res; 2001 Apr; 61(7):3212-9. PubMed ID: 11306511
[TBL] [Abstract][Full Text] [Related]
52. High frequency of hypermethylation at the 14-3-3 sigma locus leads to gene silencing in breast cancer.
Ferguson AT; Evron E; Umbricht CB; Pandita TK; Chan TA; Hermeking H; Marks JR; Lambers AR; Futreal PA; Stampfer MR; Sukumar S
Proc Natl Acad Sci U S A; 2000 May; 97(11):6049-54. PubMed ID: 10811911
[TBL] [Abstract][Full Text] [Related]
53. Characterisation of a 161 kb deletion extending from the NBR1 to the BRCA1 genes in a French breast-ovarian cancer family.
Gad S; Bièche I; Barrois M; Casilli F; Pages-Berhouet S; Dehainault C; Gauthier-Villars M; Bensimon A; Aurias A; Lidereau R; Bressac-de Paillerets B; Tosi M; Mazoyer S; Stoppa-Lyonnet D
Hum Mutat; 2003 Jun; 21(6):654. PubMed ID: 14961556
[TBL] [Abstract][Full Text] [Related]
54. Two promoters in expression of estrogen receptor messenger RNA in human breast cancer.
Hayashi S; Imai K; Suga K; Kurihara T; Higashi Y; Nakachi K
Carcinogenesis; 1997 Mar; 18(3):459-64. PubMed ID: 9067542
[TBL] [Abstract][Full Text] [Related]
55. Real-time PCR quantification of full-length and exon 11 spliced BRCA1 transcripts in human breast cancer cell lines.
Favy DA; Lafarge S; Rio P; Vissac C; Bignon YJ; Bernard-Gallon D
Biochem Biophys Res Commun; 2000 Jul; 274(1):73-8. PubMed ID: 10903898
[TBL] [Abstract][Full Text] [Related]
56. MUC1 isoform specific monoclonal antibody 6E6/2 detects preferential expression of the novel MUC1/Y protein in breast and ovarian cancer.
Hartman M; Baruch A; Ron I; Aderet Y; Yoeli M; Sagi-Assif O; Greenstein S; Stadler Y; Weiss M; Harness E; Yaakubovits M; Keydar I; Smorodinsky NI; Wreschner DH
Int J Cancer; 1999 Jul; 82(2):256-67. PubMed ID: 10389761
[TBL] [Abstract][Full Text] [Related]
57. Expression profiles of BRCA1 splice variants in asynchronous and in G1/S synchronized tumor cell lines.
Orban TI; Olah E
Biochem Biophys Res Commun; 2001 Jan; 280(1):32-8. PubMed ID: 11162473
[TBL] [Abstract][Full Text] [Related]
58. The H19 gene is expressed within both epithelial and stromal components of human invasive adenocarcinomas.
Dugimont T; Curgy JJ; Wernert N; Delobelle A; Raes MB; Joubel A; Stehelin D; Coll J
Biol Cell; 1995; 85(2-3):117-24. PubMed ID: 8785513
[TBL] [Abstract][Full Text] [Related]
59. Characterization of functional messenger RNA splice variants of BRCA1 expressed in nonmalignant and tumor-derived breast cells.
Lu M; Conzen SD; Cole CN; Arrick BA
Cancer Res; 1996 Oct; 56(20):4578-81. PubMed ID: 8840964
[TBL] [Abstract][Full Text] [Related]
60. Loss of heterozygosity of BRCA1, BRCA2 and ATM genes in sporadic invasive ductal breast carcinoma.
Rio PG; Pernin D; Bay JO; Albuisson E; Kwiatkowski F; De Latour M; Bernard-Gallon DJ; Bignon YJ
Int J Oncol; 1998 Oct; 13(4):849-53. PubMed ID: 9735416
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
